Acute crescentic glomerulonephritis as a complication of a Staphylococcus aureus abscess of bip joint prosthsis
We report a case of acute diffuse proliferative glomerulonephritis following a coagulase positive staphylococcal (S aureus) abscess around a hipjoint prosthesis. A standard work on renal pathology' describes only three personally observed cases of staphylococcal septicaemia without endocarditis, in association with proliferative glomerulonephritis, and cites a description of two cases2 associated with staphylococcal pneumonia. Furthermore, we are not aware of a previous case of acute diffuse proliferative glomerulonephritis occurring after a Staphylococcus aureus infection of a hipjoint prosthesis.
A 75 year old man had a right total hip replacement followed by a transurethral resection of prostate two months later. Over the following month he became increasingly confused and feverish. Blood and urine cultures persistently showed Staphylococcus aureus infection. He was treated with van- comycin, velosef, and amikacin, but developed uraemia despite peritoneal dialysis and died three months after the first operation.
At necropsy about 100 ml of purulent material were found in a loculated thick walled abscess around the hip prosthesis. Blood and hip abscess culture showed Staphylococcus aureus infection. Histological examination of the kidney showed diffuse proliferative glomerulonephritis. To assess the sensitivity and specificity of the latex agglutination test an initial study of 100 sera was made. These sera were all from known homosexuals presenting to a genitourinary clinic. In a further study of patients awaiting bone marrow transplantation 13 sera were examined. All sera had been stored at -80°C before examination. In addition, three further sera from one patient, taken over a period of five months were examined-the patient was a 39 year old woman suffering from relapsed acute myeloid leukaemia. The sera were examined, both by a latex agglutination test (CMV Scan, Becton and Dickinson, Baltimore, Maryland) and an IgG ELISA test (Virenz G-CMV, Northumbria Biologicals Limited, Cramlington, Northumberland). The tests were performed exactly as stated in the instructions.
In the initial study of 100 sera from homosexuals there was 99% correlation between the two tests. Eighty sera gave positive results by both methods and 19, negative results. The remaining serum gave a positive result by latex but a negative result by ELISA. When both tests were repeated on this serum, both gave positive results. Of 100 sera examined by the ELISA test, there was one false negative result. In the study of sera from patients awaiting marrow transplantation there was a 100% correlation between the two tests. Of the transplant recipients, eight (62%) were positive and five (38%) negative.
The initial serum from the patient who had serial studies was received on 31 December 1985 and was positive by both methods. A further serum was received on 24 April 1986 and was still positive by both methods, though the ELISA was only weakly positive.
Two further sera, received on 21 and 29 May 1986, were negative by both methods. These results were confirmed on retesting of the stored sera.
We agree with the findings of previously published studies3' that the latex agglutination test for CMV is both sensitive and specific. Furthermore, the test is rapid and easy to perform, making it suitable for use in non-specialist laboratories. Even in virology laboratories it compares favourably with other methods, particularly complement fixation tests which are known to be Coagulation changes in homozygous sickle cell disease in Nigeria Abnormalities in haemostasis have been described in sickle cell disease, and recently increased fibrinogen concentrations' and increased viscosity2 have been observed. These have been related to possible abnormalities in plasma proteins in patients with sickle cell disease (SCD). No study has been designed to examine such changes in Nigerian patients, despite the large numbers of patients with the disease in our population. The patients studied included 70 (20 men and 50 women) patients with SCD attending the University of Benin Teaching Hospital, Nigeria. Their routine checks included haemoglobin concentration or packed cell volume, administration of antimalarial drug (proguanil or pyrimethamine), and folic acid supplementation. The presence of joint pains, fever, and bone pains of sufficient gravity to warrant immediate admission were considered to constitute a crisis. Seventy five healthy non-sicklers served as controls. A venous blood sample from each patient was assessed for platelet count, fibrinogen, factors V and VIII.
The results are shown in the table. There was an increased platelet count (p < 0 05), fibrinogen concentration, (p < 0 005), and factor VIII p < 0-01, but a reduced factor V value (p < 0-0005) in patients with SCD in stable state compared with non-sicklers. SCD in crisis also showed an increased platelet count (p < 0-0005), fibrinogen concentration (p < 0-0005), higher factor VIII (p < 0-0005) and lower factor V value (p < 00005) than patients with SCD in steady state.
The cause of the increased factor VIII value may be fever, stress, and infections which are common complications during crisis. The changes in factor V and factor VIII values observed in this study are similar to 
